See analyst estimates and all valuation multiples for Biopharmaceuticals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $1.00T | 15.7x | 34.8x | |
| $527B | 5.6x | 14.7x | |
| $459B | 7.5x | 17.6x | |
| $366B | 4.7x | 11.9x | |
| $321B | 5.5x | 15.8x | |
| $296B | 5.4x | 13.1x | |
| $293B | 4.5x | 9.8x | |
| $265B | 5.5x | 11.4x | |
| $223B | 6.1x | 12.6x | |
| $190B | 3.1x | 7.7x | |
| $172B | 5.9x | 10.8x | |
| $148B | 3.1x | 7.9x | |
| $125B | 2.4x | 7.9x | |
| $123B | 2.8x | 8.3x | |
| $115B | 9.6x | 21.2x | |
| $83.6B | 10.5x | 20.7x | |
| $82.1B | 1.5x | 7.4x | |
| $76.2B | 2.6x | 9.8x | |
| $75.4B | 3.0x | 10.6x | |
| $66.2B | 4.1x | 12.2x | |
| $60.6B | 6.4x | 14.7x | |
| $54.9B | 11.8x | 39.2x | |
| $54.8B | 11.6x | 38.4x | |
| $53.2B | 5.6x | 19.1x | |
| $52.2B | 3.0x | 10.2x | |
| $44.3B | 7.1x | 24.9x | |
| $39.3B | 3.0x | 14.8x | |
| $37.0B | 3.4x | 15.6x | |
| $33.5B | 11.7x | 32.8x | |
| $29.9B | 3.0x | 9.8x | |
| $29.1B | 1.9x | 7.8x | |
| $28.1B | 2.2x | 9.3x | |
| $28.1B | 2.0x | 6.8x | |
| $27.2B | 12.9x | 33.6x | |
| $24.8B | 8.3x | 8.6x | |
| $22.6B | 2.2x | 6.3x | |
| $19.3B | 61.0x | n/a | |
| $18.8B | 9.7x | 95.3x | |
| $17.7B | 2.0x | 8.3x | |
| $17.6B | 4.8x | 12.6x | |
| $17.4B | 112.3x | 209.1x | |
| $15.4B | 10.9x | 33.2x | |
| $14.8B | 31.2x | -1471.6x | |
| $14.4B | 3.0x | 11.2x | |
| $14.0B | 4.5x | 11.7x | |
| $13.9B | 4.5x | 12.1x | |
| $13.4B | 47.9x | -290.1x | |
| $13.1B | 2.2x | 13.8x | |
| $12.8B | 4.5x | 19.5x | |
| $12.8B | 2.1x | 14.5x | |
| $12.3B | 4.0x | 9.9x | |
| $12.0B | 3.0x | 12.0x | |
| $12.0B | 3.7x | 15.5x | |
| $11.8B | n/a | n/a | |
| $11.7B | 0.3x | 5.0x | |
| $11.2B | 3.3x | 7.9x | |
| $11.1B | 4.0x | 15.4x | |
| $11.1B | 2.9x | 12.0x | |
| $11.0B | 2.5x | 6.6x | |
| $11.0B | 5.0x | 13.4x | |
| $10.9B | 7.0x | 28.0x | |
| $10.5B | 12.2x | 40.0x | |
| $10.4B | 3.7x | 13.4x | |
| $10.3B | 1.6x | 5.3x | |
| $9.5B | 1.5x | 11.9x | |
| $9.4B | 928.1x | -39.4x | |
| $9.3B | 6.9x | 10.6x | |
| $8.4B | n/a | n/a | |
| $8.1B | 103.6x | 18147.3x | |
| $8.1B | 1.6x | 13.0x | |
| $7.9B | n/a | n/a | |
| $7.7B | 2.9x | 4.2x | |
| $7.6B | 2.1x | 10.2x | |
| $7.5B | 3.9x | 19.1x | |
| $7.4B | 4.7x | 23.5x | |
| $7.3B | 17.8x | -2970.3x | |
| $7.2B | 23932.4x | -24.0x | |
| $7.1B | 2.3x | 10.2x | |
| $6.9B | 2.9x | 8.8x | |
| $6.6B | 2.2x | 9.7x | |
| $6.5B | 1.5x | 8.7x | |
| $6.5B | 8.5x | 31.2x | |
| $6.4B | 2.0x | 8.5x | |
| $6.3B | 3.6x | 23.8x | |
| $6.2B | n/a | n/a | |
| $6.2B | n/a | n/a | |
| $6.0B | 1.8x | 7.1x | |
| $5.9B | n/a | n/a | |
| $5.9B | 16.3x | 24.2x | |
| $5.8B | 3.8x | 42.8x | |
| $5.7B | 6.7x | 23.3x | |
| $5.5B | 9.2x | 27.7x | |
| $5.3B | 1.9x | 5.2x | |
| $5.3B | 2.7x | 10.1x | |
| $5.2B | n/a | -19.4x | |
| $5.0B | 5.9x | 30.1x | |
| $4.9B | 13.5x | -73.7x | |
| $4.9B | 1.8x | 10.7x | |
| $4.8B | 9.9x | 30.0x | |
| $4.7B | n/a | -28.4x | |
| $4.7B | 9.0x | 23.5x | |
| $4.5B | 4.9x | 13.5x | |
| $4.3B | 8.5x | 18.4x | |
| $4.3B | 10.1x | 30.6x | |
| $4.2B | 4.0x | 18.4x | |
| $4.2B | 4.9x | 18.2x | |
| $4.1B | 2.9x | 10.7x | |
| $4.1B | n/a | n/a | |
| $4.0B | n/a | n/a | |
| $4.0B | n/a | -10.0x | |
| $3.9B | n/a | n/a | |
| $3.8B | 2.6x | 10.1x | |
| $3.8B | n/a | -33.9x | |
| $3.7B | 2.2x | 10.9x | |
| $3.6B | 10.0x | -1866.8x | |
| $3.5B | 30.3x | -554.1x | |
| $3.5B | 5.3x | 14.2x | |
| $3.5B | 5.2x | 15.1x | |
| $3.5B | 5.0x | 14.5x | |
| $3.4B | n/a | n/a | |
| $3.4B | 2.5x | 9.0x | |
| $3.4B | 123.0x | -16.0x | |
| $3.3B | 2.6x | 12.2x | |
| $3.3B | 6.6x | 368.8x | |
| $3.0B | 1.4x | 9.6x | |
| $3.0B | 6.7x | -47.3x | |
| $3.0B | 15.2x | 26.3x | |
| $2.8B | 4.2x | 26.3x | |
| $2.8B | n/a | n/a | |
| $2.7B | 4.6x | 20.6x | |
| $2.7B | 3.8x | 21.1x | |
| $2.7B | 4.3x | 14.1x | |
| $2.7B | n/a | n/a | |
| $2.6B | 4.2x | 10.3x | |
| $2.6B | 35.1x | -19.6x | |
| $2.6B | 61.3x | -12.8x | |
| $2.6B | 6.4x | 19.0x | |
| $2.5B | 8.7x | 107.4x | |
| $2.4B | 2.9x | 14.6x | |
| $2.4B | n/a | n/a | |
| $2.4B | n/a | -10.2x | |
| $2.4B | 43.5x | n/a | |
| $2.4B | 12.8x | 37.8x | |
| $2.3B | n/a | n/a | |
| $2.3B | 5.9x | 17.0x | |
| $2.2B | n/a | -10.3x | |
| $2.2B | 7.1x | 18.5x | |
| $2.2B | 2.5x | 9.6x | |
| $2.1B | 3.4x | 13.4x | |
| $2.1B | 13.5x | 29.8x | |
| $2.1B | 2.6x | 4.5x | |
| $2.1B | 7.5x | 29.2x | |
| $2.1B | 13.6x | 34.1x | |
| $2.0B | n/a | -11.8x | |
| $2.0B | 7.3x | 58.5x | |
| $1.9B | n/a | n/a | |
| $1.9B | 7.8x | -5.3x | |
| $1.9B | 2.8x | 13.3x | |
| $1.8B | 16.9x | 328.3x | |
| $1.8B | n/a | n/a | |
| $1.7B | 6.2x | 11.7x | |
| $1.7B | n/a | -10.2x | |
| $1.7B | 6.7x | 288.2x | |
| $1.7B | 8.8x | 151.6x | |
| $1.7B | 4.1x | -393.2x | |
| $1.7B | n/a | n/a | |
| $1.7B | 2.3x | 6.3x | |
| $1.6B | 3.9x | 13.5x | |
| $1.6B | n/a | -11.3x | |
| $1.6B | 0.7x | 4.1x | |
| $1.6B | 62.7x | -6.4x | |
| $1.5B | 10.5x | 26.1x | |
| $1.5B | 5.3x | 28.6x | |
| $1.5B | n/a | n/a | |
| $1.5B | 12.3x | -28.8x | |
| $1.5B | n/a | n/a | |
| $1.4B | 6.1x | 34.1x | |
| $1.4B | n/a | n/a | |
| $1.4B | 4.8x | 9.5x | |
| $1.4B | 8.4x | -5.3x | |
| $1.4B | 31.7x | 201.2x | |
| $1.4B | n/a | -15.6x | |
| $1.4B | 4.1x | 56.6x | |
| $1.4B | 21.8x | -12.8x | |
| $1.4B | n/a | -10.3x | |
| $1.3B | 37.3x | n/a | |
| $1.3B | 10.7x | 40.3x | |
| $1.3B | n/a | n/a | |
| $1.2B | n/a | -6.6x | |
| $1.2B | 541.2x | n/a | |
| $1.2B | n/a | -8.5x | |
| $1.2B | n/a | -7.5x | |
| $1.2B | 2.1x | -52.1x | |
| $1.2B | 1.2x | 5.0x | |
| $1.2B | 3.0x | 5.2x | |
| $1.2B | 6.8x | -8.5x | |
| $1.2B | 3.2x | 37.5x | |
| $1.2B | 0.5x | 4.3x | |
| $1.1B | 429.9x | -7.5x | |
| $1.1B | 2.9x | 43.3x | |
| $1.1B | n/a | -5.6x | |
| $1.1B | 2.3x | 13.0x | |
| $1.1B | 9.3x | 30.0x | |
| $1.1B | 1.4x | 5.6x | |
| $1.1B | 3.7x | 7.4x | |
| $1.1B | 1076.5x | -10.9x | |
| $1.1B | 9.6x | -9.3x | |
| $1.1B | n/a | n/a | |
| $1.1B | n/a | n/a | |
| $1.1B | n/a | -10.9x | |
| $1.0B | 2.7x | 11.5x | |
| $1.0B | 1.7x | -7.5x | |
| $996M | 1.6x | 8.1x | |
| $960M | 2.4x | 2.7x | |
| $948M | 1133.5x | -84.0x | |
| $929M | 2.0x | 9.7x | |
| $903M | 108317.7x | -7.9x | |
| $872M | n/a | n/a | |
| $848M | n/a | -7.2x | |
| $842M | 90.1x | -7.2x | |
| $840M | 608.4x | -152.1x | |
| $831M | 2.9x | 12.7x | |
| $823M | 64.5x | -2.6x | |
| $802M | 58.8x | n/a | |
| $729M | n/a | n/a | |
| $725M | n/a | n/a | |
| $723M | n/a | n/a | |
| $702M | 18.0x | -11.2x | |
| $666M | n/a | n/a | |
| $654M | 17.5x | 67.6x | |
| $652M | n/a | -4.3x | |
| $627M | n/a | -2.8x | |
| $613M | 86.6x | -3.9x | |
| $612M | 4.7x | -3.7x | |
| $607M | n/a | n/a | |
| $591M | 20.3x | -2.9x | |
| $581M | n/a | n/a | |
| $574M | 2.9x | -5.4x | |
| $564M | n/a | n/a | |
| $562M | 36.3x | -11.4x | |
| $560M | 3.2x | 20.0x | |
| $553M | n/a | n/a | |
| $545M | n/a | n/a | |
| $539M | n/a | -3.7x | |
| $523M | 20398.2x | n/a | |
| $511M | 8.0x | -23.0x | |
| $510M | n/a | -3.3x | |
| $503M | n/a | n/a | |
| $501M | 3.4x | -4.1x | |
| $499M | 38.4x | -6.4x | |
| $487M | n/a | n/a | |
| $486M | n/a | n/a | |
| $459M | 33.8x | n/a | |
| $439M | n/a | n/a | |
| $437M | 2.3x | 9.6x | |
| $436M | 1.3x | 4.8x | |
| $428M | 18.8x | -8.3x | |
| $423M | 1.3x | 9.4x | |
| $408M | 6.3x | 24.5x | |
| $406M | 89.3x | -13.1x | |
| $403M | 2.2x | 9.2x | |
| $395M | n/a | n/a | |
| $381M | 3.0x | 33.9x | |
| $379M | 1.3x | 10.8x | |
| $371M | 7.8x | -6.1x | |
| $370M | n/a | n/a | |
| $354M | 34.8x | -8.1x | |
| $337M | n/a | n/a | |
| $334M | n/a | n/a | |
| $327M | 53.4x | -1.5x | |
| $313M | 3.2x | 10.8x | |
| $310M | 0.8x | 9.1x | |
| $309M | 16.2x | -3.9x | |
| $309M | n/a | n/a | |
| $304M | 4.4x | 32.8x | |
| $283M | 1257.5x | -6.3x | |
| $282M | 1.2x | n/a | |
| $276M | 4.1x | 8.9x | |
| $264M | 4.7x | n/a | |
| $263M | n/a | n/a | |
| $260M | 5.7x | 45.8x | |
| $256M | 2.9x | -12.0x | |
| $255M | n/a | n/a | |
| $253M | n/a | n/a | |
| $253M | 69.6x | -4.6x | |
| $251M | n/a | n/a | |
| $234M | n/a | -34.4x | |
| $234M | 12.1x | -5.5x | |
| $231M | 52764.8x | -2.6x | |
| $230M | 1.6x | 15.2x | |
| $227M | n/a | n/a | |
| $227M | 5.0x | 24.7x | |
| $226M | 5.6x | -29.2x | |
| $220M | 31.3x | -2.5x | |
| $217M | 2.9x | -0.8x | |
| $209M | n/a | n/a | |
| $206M | 28.8x | -6.4x | |
| $200M | n/a | -3.2x | |
| $196M | 2.4x | 94.3x | |
| $192M | n/a | n/a | |
| $190M | n/a | -3.2x | |
| $184M | n/a | n/a | |
| $182M | 2.8x | n/a | |
| $172M | 34.5x | -2.5x | |
| $172M | 3.1x | 789.8x | |
| $165M | 15.3x | n/a | |
| $161M | 19.0x | -16.8x | |
| $157M | 9.4x | -3.8x | |
| $155M | 29.1x | -13.4x | |
| $151M | 5.9x | -4.2x | |
| $145M | 4.7x | 7.0x | |
| $138M | 4.4x | -1.9x | |
| $137M | n/a | n/a | |
| $134M | 4.0x | -0.7x | |
| $132M | 7.8x | -2.3x | |
| $130M | 32.5x | -9.3x | |
| $127M | 13.9x | -5.6x | |
| $126M | n/a | n/a | |
| $122M | 2.0x | n/a | |
| $120M | 9.4x | -4.3x | |
| $119M | 22.4x | -12.6x | |
| $118M | n/a | -0.8x | |
| $117M | n/a | -9.0x | |
| $115M | n/a | n/a | |
| $115M | 5.4x | 53.1x | |
| $110M | n/a | -29.9x | |
| $109M | 9.1x | 163.8x | |
| $109M | n/a | n/a | |
| $109M | 1.5x | 9.2x | |
| $108M | n/a | n/a | |
| $106M | n/a | n/a | |
| $91.6M | 64.0x | -17.1x | |
| $86.4M | n/a | n/a | |
| $79.0M | n/a | n/a | |
| $75.9M | 0.9x | 5.4x | |
| $74.4M | n/a | n/a | |
| $70.9M | n/a | n/a | |
| $69.2M | n/a | n/a | |
| $68.9M | 6.9x | 15.0x | |
| $68.0M | n/a | n/a | |
| $65.2M | n/a | n/a | |
| $64.4M | n/a | n/a | |
| $63.2M | n/a | n/a | |
| $61.1M | 0.3x | -1.3x | |
| $57.2M | n/a | n/a | |
| $56.2M | n/a | n/a | |
| $56.0M | n/a | n/a | |
| $55.6M | n/a | -9.2x | |
| $51.5M | 5.1x | 2.2x | |
| $50.7M | n/a | n/a | |
| $50.2M | n/a | n/a | |
| $47.9M | n/a | n/a | |
| $45.9M | n/a | n/a | |
| $44.3M | 30.8x | -55.7x | |
| $44.1M | n/a | n/a | |
| $43.1M | n/a | -3.4x | |
| $42.9M | 10.8x | -1.4x | |
| $39.2M | 5.2x | n/a | |
| $38.9M | 4.9x | -1.9x | |
| $38.0M | 0.4x | -0.6x | |
| $37.9M | n/a | -5.8x | |
| $37.8M | 10.4x | -9.4x | |
| $36.6M | 42.1x | -3.5x | |
| $36.4M | n/a | n/a | |
| $36.0M | 55.1x | -3.5x | |
| $35.3M | n/a | n/a | |
| $35.2M | n/a | n/a | |
| $33.5M | n/a | n/a | |
| $31.9M | 11.7x | -6.0x | |
| $31.2M | 8.1x | n/a | |
| $28.3M | 8.0x | -4.7x | |
| $28.0M | n/a | n/a | |
| $27.4M | n/a | n/a | |
| $26.3M | n/a | n/a | |
| $26.1M | 11.9x | -0.4x | |
| $25.2M | 18.7x | -9.0x | |
| $23.8M | n/a | n/a | |
| $23.4M | n/a | -13.1x | |
| $22.5M | 110.5x | -4.9x | |
| $21.3M | n/a | n/a | |
| $21.2M | n/a | n/a | |
| $20.6M | n/a | n/a | |
| $20.1M | n/a | n/a | |
| $19.9M | 2.8x | 8.0x | |
| $19.9M | n/a | n/a | |
| $18.8M | n/a | -4.2x | |
| $18.6M | n/a | -4.5x | |
| $18.3M | 13.1x | -1.1x | |
| $17.9M | n/a | n/a | |
| $17.6M | n/a | n/a | |
| $17.5M | n/a | n/a | |
| $16.5M | n/a | n/a | |
| $16.2M | 7.3x | 1.6x | |
| $15.9M | 36.5x | -2.5x | |
| $15.9M | n/a | n/a | |
| $15.6M | n/a | n/a | |
| $14.8M | 2.7x | -5.7x | |
| $14.6M | 1.0x | -8.7x | |
| $14.5M | n/a | n/a | |
| $14.3M | n/a | n/a | |
| $14.2M | n/a | n/a | |
| $14.0M | n/a | n/a | |
| $13.3M | 13.3x | -0.5x | |
| $13.2M | n/a | n/a | |
| $12.9M | 2.1x | -0.2x | |
| $12.1M | 159.0x | -5.3x | |
| $12.0M | n/a | n/a | |
| $12.0M | n/a | n/a | |
| $12.0M | 8.0x | -35.6x | |
| $11.1M | n/a | n/a | |
| $10.4M | n/a | -2.7x | |
| $10.2M | n/a | -2.1x | |
| $10.0M | n/a | n/a | |
| $9.7M | n/a | n/a | |
| $9.7M | 1.6x | -1.0x | |
| $9.7M | 5.6x | -0.7x | |
| $9.7M | 9.5x | -38.6x | |
| $9.4M | n/a | n/a | |
| $9.0M | n/a | n/a | |
| $8.4M | n/a | n/a | |
| $8.1M | n/a | -2.3x | |
| $8.0M | n/a | n/a | |
| $7.8M | n/a | -2.5x | |
| $7.8M | n/a | n/a | |
| $7.7M | 2.2x | -3.0x | |
| $7.6M | n/a | n/a | |
| $7.4M | n/a | n/a | |
| $7.4M | n/a | n/a | |
| $6.9M | 63.5x | -2.3x | |
| $6.8M | n/a | n/a | |
| $6.8M | n/a | n/a | |
| $6.3M | n/a | n/a | |
| $5.3M | 8.2x | -4.5x | |
| $5.0M | 5.0x | n/a | |
| $4.3M | 3.2x | -1.1x | |
| $4.0M | n/a | n/a | |
| $3.6M | n/a | n/a | |
| $3.2M | n/a | n/a | |
| $3.1M | n/a | n/a | |
| $3.0M | 2.4x | -0.4x | |
| $3.0M | n/a | n/a | |
| $2.9M | n/a | n/a | |
| $2.7M | n/a | n/a | |
| $2.5M | n/a | n/a | |
| $2.4M | n/a | n/a | |
| $2.4M | n/a | n/a | |
| $2.3M | n/a | n/a | |
| $2.2M | n/a | n/a | |
| $2.2M | n/a | n/a | |
| $2.1M | n/a | n/a | |
| $1.8M | n/a | n/a | |
| $1.6M | n/a | -2.1x | |
| $1.4M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| $0.8M | n/a | n/a | |
| $0.6M | n/a | -1.2x | |
| $0.1M | n/a | n/a | |
| $0.1M | n/a | n/a | |
| -$0.2M | n/a | n/a | |
| -$0.5M | n/a | n/a | |
| -$0.6M | n/a | n/a | |
| -$0.9M | n/a | n/a | |
| -$1.3M | n/a | 0.4x | |
| -$1.5M | -1.0x | n/a | |
| -$4.4M | n/a | n/a | |
| -$6.5M | n/a | n/a | |
| -$17.8M | n/a | n/a | |
| -$31.8M | n/a | n/a | |
| -$60.0M | -3.5x | 0.4x | |
| -$101M | n/a | 0.6x | |
| -$1.4B | -4.5x | 4.5x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Biopharmaceuticals